IPOPLUS

2,195.6

+2.8 +0.13%

18 Jun 2026

NSE Listed · Pharmaceuticals

J B Chemicals and Pharma (JBCHEPHARM)

Volume: 4,801Avg Vol 1W: 54,848Avg Vol 1M: 1,50,33352W Range:1,603.52,300
₹2,195.6 0.13%
Key Ratios
Updated 3h ago
Market Cap₹36,309 Cr
Current Price₹2,195.6
Previous Close₹2,192.8
High / Low (52w)₹2,300 / ₹1,603.5
Volume4,801
Avg Vol (1W)54,848
Avg Vol (1M)1,50,333
Stock P/E46.69
Book Value₹258.98
Dividend Yield0.97%
ROE17.06%
ROA14.28%
Revenue (TTM)
Revenue Growth5.87%
Profit Margin17.1%
Total Debt₹0 Cr
Shares Outstanding16 Cr
Face Value₹1
EPS (TTM)₹6.35
P/B8.53
Debt / Equity0
50 DMA₹2,173.82
200 DMA₹2,047.07
Day change+0.13%
Price Chart
2,195.6 29.70% · 1Y
2261167813.5L
2025-10-21
2026-06-16

20-day avg volume: 1.3L shares

Pros
  • Healthy return on equity of 17.1%.
  • Company is almost debt-free.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹904 Cr₹1,065 Cr₹1,085 Cr₹1,094 Cr₹949 Cr₹963 Cr₹1,001 Cr₹1,004 Cr₹862 Cr₹845 Cr₹882 Cr₹896 Cr₹762 Cr₹793 Cr₹809 Cr₹785 Cr₹625 Cr₹601 Cr₹593 Cr₹606 Cr₹528 Cr₹548 Cr₹444 Cr₹522 Cr₹444 Cr
EBITDA₹163 Cr₹269 Cr₹281 Cr₹273 Cr₹194 Cr₹221 Cr₹239 Cr₹245 Cr₹174 Cr₹196 Cr₹219 Cr₹206 Cr₹136 Cr₹150 Cr₹158 Cr₹148 Cr₹105 Cr₹116 Cr₹131 Cr₹159 Cr₹133 Cr₹210 Cr₹101 Cr₹161 Cr₹78 Cr
Net Profit₹101 Cr₹198 Cr₹208 Cr₹202 Cr₹146 Cr₹162 Cr₹175 Cr₹177 Cr₹126 Cr₹134 Cr₹151 Cr₹142 Cr₹88 Cr₹106 Cr₹111 Cr₹105 Cr₹85 Cr₹84 Cr₹98 Cr₹119 Cr₹101 Cr₹154 Cr₹74 Cr₹119 Cr₹50 Cr
EPS6.3212.4513.0812.759.1710.241111.168.068.469.549.0711.1913.5714.2613.5610.9810.8512.6515.3813.0219.949.5515.456.3
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹4,208 Cr₹3,956 Cr₹3,521 Cr₹3,159 Cr₹2,463 Cr₹2,155 Cr₹1,825 Cr
EBITDA₹985 Cr₹899 Cr₹796 Cr₹591 Cr₹510 Cr₹604 Cr₹362 Cr
Net Profit₹709 Cr₹660 Cr₹553 Cr₹410 Cr₹385 Cr₹448 Cr₹272 Cr
EPS44.4541.5634.8552.3449.8257.9634.2
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹4,969 Cr₹4,274 Cr₹3,994 Cr₹3,554 Cr₹2,607 Cr₹2,238 Cr₹1,821 Cr
Total Liabilities₹809 Cr₹840 Cr₹1,071 Cr₹1,074 Cr₹469 Cr₹425 Cr₹383 Cr
Equity₹4,159 Cr₹3,433 Cr₹2,923 Cr₹2,480 Cr₹2,139 Cr₹1,813 Cr₹1,438 Cr
Total Debt₹0 Cr₹0 Cr₹24 Cr₹383 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹960 Cr₹1,103 Cr₹933 Cr₹721 Cr₹305 Cr₹457 Cr₹367 Cr
Investing₹-586 Cr₹-296 Cr₹-404 Cr₹-962 Cr₹2 Cr₹-231 Cr₹24 Cr
Financing₹-123 Cr₹-580 Cr₹-385 Cr₹357 Cr₹-138 Cr₹-87 Cr₹-306 Cr
Free Cash Flow₹960 Cr₹1,103 Cr₹933 Cr₹721 Cr₹305 Cr₹457 Cr₹367 Cr
Shareholding
Promoter 48.8% Institutions 37.72% Public 13.48%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search